In this special edition of the Business of Cannabis Podcast, we go From Anecdote to Evidence with Dr Anne Katrin Schlag, Head of Research at Drug Science, and Graham Woodward, Chief Operating Officer at Releaf. Together, they explore how the UK can move from anecdotal patient stories to robust, real-world evidence — and why this shift is vital for expanding safe, trusted access to cannabis-based medicines. They unpack how clinics like Releaf are investing in quality-of-life surveys and data-driven patient care, what this means for regulators like NICE, and whether more solid evidence can finally open doors with the BMA, Royal Colleges and wider healthcare system. For anyone interested in how data and patient outcomes can unlock the next stage of UK medical cannabis, this is a conversation not to miss.